Condition
Oral Anticoagulant
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05469308Not ApplicableUnknownPrimary
Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation
NCT05378308Recruiting
NOACs Use in AF or VTE (SUNSHINE Registry)
NCT04684056UnknownPrimary
Laboratory Assessment of the Concentration of Direct Oral Anticoagulants in Patients With Atrial Fibrillation
Showing all 3 trials